Schultze-Lutter Frauke, Michel Chantal, Ruhrmann Stephan, Schimmelmann Benno G
University Hospital of Child and Adolescent Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland; and
University Hospital of Child and Adolescent Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland; and.
Schizophr Bull. 2014 Nov;40(6):1499-508. doi: 10.1093/schbul/sbt171. Epub 2013 Dec 18.
Section III of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) lists attenuated psychosis syndrome as a condition for further study. One important question is its prevalence and clinical significance in the general population.
Analyses involved 1229 participants (age 16-40 years) from the general population of Canton Bern, Switzerland, enrolled from June 2011 to July 2012. "Symptom," "onset/worsening," "frequency," and "distress/disability" criteria of attenuated psychosis syndrome were assessed using the structured interview for psychosis-risk syndromes. Furthermore, help-seeking, psychosocial functioning, and current nonpsychotic axis I disorders were surveyed. Well-trained psychologists performed assessments using the computer-assisted telephone interviewing technique.
The symptom criterion was met by 12.9% of participants, onset/worsening by 1.1%, frequency by 3.8%, and distress/disability by 7.0%. Symptom, frequency, and distress/disability were met by 3.2%. Excluding trait-like attenuated psychotic symptoms (APS) decreased the prevalence to 2.6%, while adding onset/worsening reduced it to 0.3%. APS were associated with functional impairments, current mental disorders, and help-seeking although they were not a reason for help-seeking. These associations were weaker for attenuated psychosis syndrome.
At the population level, only 0.3% met current attenuated psychosis syndrome criteria. Particularly, the onset/worsening criterion, originally included to increase the likelihood of progression to psychosis, lowered its prevalence. Because progression is not required for a self-contained syndrome, a revision of the restrictive onset criterion is proposed to avoid the exclusion of 2.3% of persons who experience and are distressed by APS from mental health care. Secondary analyses suggest that a revised syndrome would also possess higher clinical significance than the current syndrome.
《精神疾病诊断与统计手册》第五版(DSM - 5)第三部分将精神病性症状衰减综合征列为有待进一步研究的病症。一个重要问题是其在普通人群中的患病率及临床意义。
分析纳入了2011年6月至2012年7月从瑞士伯尔尼州普通人群中招募的1229名参与者(年龄16 - 40岁)。使用精神病风险综合征结构化访谈评估精神病性症状衰减综合征的“症状”“起病/加重”“频率”和“痛苦/残疾”标准。此外,还调查了寻求帮助情况、社会心理功能以及当前的非精神病性轴I障碍。训练有素的心理学家采用计算机辅助电话访谈技术进行评估。
12.9%的参与者符合症状标准,1.1%符合起病/加重标准,3.8%符合频率标准,7.0%符合痛苦/残疾标准。3.2%的参与者符合症状、频率和痛苦/残疾标准。排除特质样精神病性症状衰减(APS)后患病率降至2.6%,而加上起病/加重标准后则降至0.3%。APS与功能损害、当前精神障碍及寻求帮助有关,尽管它并非寻求帮助的原因。这些关联在精神病性症状衰减综合征中较弱。
在人群层面,仅0.3%的人符合当前精神病性症状衰减综合征标准。特别是,最初为增加发展为精神病可能性而纳入的起病/加重标准降低了其患病率。由于自成一体的综合征并不要求有病情进展,因此建议修订这一严格的起病标准,以避免将2.3%经历APS并受其困扰的人排除在精神卫生保健之外。二次分析表明,修订后的综合征也将比当前综合征具有更高的临床意义。